Literature DB >> 2926384

Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type.

S Hoyer1, R Nitsch.   

Abstract

A massive cerebral release of amino acids and ammonia was found in early-onset dementia of Alzheimer type. Aspartate and glycine were liberated in high concentrations, whereas glutamate remained rather unchanged. This excess cerebral protein catabolism is due to a 44% reduction in cerebral glucose metabolism. Whereas glutamate and other glucoplastic amino acids may substitute glucose, elevated aspartate may contribute to neuronal damage. The results are discussed with respect to a possible neuronal insulin/insulin receptor deficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926384     DOI: 10.1007/BF01258634

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  25 in total

1.  Oxidative metabolism of the cerebral cortex of the rat in severe insulin-induced hypoglycaemia.

Authors:  K Norberg; B K Siesiö
Journal:  J Neurochem       Date:  1976-02       Impact factor: 5.372

2.  Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

Authors:  A W Procter; A M Palmer; P T Francis; S L Lowe; D Neary; E Murphy; R Doshi; D M Bowen
Journal:  J Neurochem       Date:  1988-03       Impact factor: 5.372

3.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  [The amino acid metabolism in normal human brain].

Authors:  S Hoyer
Journal:  Klin Wochenschr       Date:  1970-10-15

5.  Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids.

Authors:  U Lying-Tunell; B S Lindblad; H O Malmlund; B Persson
Journal:  Acta Neurol Scand       Date:  1981-06       Impact factor: 3.209

6.  Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry.

Authors:  G A Werther; A Hogg; B J Oldfield; M J McKinley; R Figdor; A M Allen; F A Mendelsohn
Journal:  Endocrinology       Date:  1987-10       Impact factor: 4.736

7.  Delayed neurotoxicity of excitatory amino acids in vitro.

Authors:  S M Rothman; J H Thurston; R E Hauhart
Journal:  Neuroscience       Date:  1987-08       Impact factor: 3.590

8.  Phosphofructokinase activity in the brain in Alzheimer's disease.

Authors:  N R Sims; J P Blass; C Murphy; D M Bowen; D Neary
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

9.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

10.  Glutamate activates multiple single channel conductances in hippocampal neurons.

Authors:  C E Jahr; C F Stevens
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

View more
  38 in total

1.  Alzheimer disease: Insulin resistance and AD--extending the translational path.

Authors:  Suzanne Craft
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

Review 2.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 3.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

Review 4.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

5.  Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

Authors:  R E Tato; A Frank; A Hernanz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 6.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.

Authors:  Thomas Arendt; Jens Stieler; Max Holzer
Journal:  J Neural Transm (Vienna)       Date:  2014-12-06       Impact factor: 3.575

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 8.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

Authors:  Fernanda G De Felice
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

9.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

Review 10.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.